IL147875A0 - Calcilytic compounds - Google Patents

Calcilytic compounds

Info

Publication number
IL147875A0
IL147875A0 IL14787500A IL14787500A IL147875A0 IL 147875 A0 IL147875 A0 IL 147875A0 IL 14787500 A IL14787500 A IL 14787500A IL 14787500 A IL14787500 A IL 14787500A IL 147875 A0 IL147875 A0 IL 147875A0
Authority
IL
Israel
Prior art keywords
calcilytic compounds
calcilytic
compounds
Prior art date
Application number
IL14787500A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp Nps Ph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp Nps Ph filed Critical Smithkline Beecham Corp Nps Ph
Publication of IL147875A0 publication Critical patent/IL147875A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14787500A 1999-07-31 2000-07-31 Calcilytic compounds IL147875A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14677899P 1999-07-31 1999-07-31
PCT/US2000/020834 WO2001008673A1 (en) 1999-07-31 2000-07-31 Calcilytic compounds

Publications (1)

Publication Number Publication Date
IL147875A0 true IL147875A0 (en) 2002-08-14

Family

ID=22518969

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14787500A IL147875A0 (en) 1999-07-31 2000-07-31 Calcilytic compounds

Country Status (21)

Country Link
EP (1) EP1200076A4 (xx)
JP (1) JP2003505502A (xx)
KR (1) KR20020016928A (xx)
CN (1) CN1367687A (xx)
AU (1) AU764716B2 (xx)
BR (1) BR0012921A (xx)
CA (1) CA2380081A1 (xx)
CO (1) CO5180628A1 (xx)
CZ (1) CZ2002360A3 (xx)
EC (1) ECSP003590A (xx)
HK (1) HK1046238A1 (xx)
HU (1) HUP0202167A3 (xx)
IL (1) IL147875A0 (xx)
MX (1) MXPA02001204A (xx)
NO (1) NO20020466L (xx)
PE (1) PE20010459A1 (xx)
PL (1) PL353318A1 (xx)
TR (1) TR200200278T2 (xx)
UY (1) UY26265A1 (xx)
WO (1) WO2001008673A1 (xx)
ZA (1) ZA200200784B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030018203A1 (en) 2002-07-17 2003-01-23 Largo Maria Amparo Calcilytic compounds
AR030684A1 (es) * 2000-01-24 2003-09-03 Smithkline Beecham Corp Compuestos calciliticos, uso de dichos compuestos en la manufactura de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
TWI316511B (en) 2002-11-26 2009-11-01 Smithkline Beecham Corp Calcilytic compounds
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
TW200845956A (en) * 2006-12-18 2008-12-01 Smithkline Beecham Corp Calcilytic compounds
WO2013098588A1 (en) * 2011-12-27 2013-07-04 Ubaldo Armato Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
CN108420814A (zh) * 2017-02-15 2018-08-21 四川大学 一种nps-2143用于抗菌的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA002984B1 (ru) * 1996-04-09 2002-12-26 Эн Пи Эс Фармасьютикалз, Инк. Кальцилитические соединения, фармацевтические композиции и способ скрининга кальцилитических соединений
MY121054A (en) * 1998-04-08 2005-12-30 Smithkline Beecham Corp Calcilytic compounds as calcium receptor antagonists.
AR014975A1 (es) * 1998-04-08 2001-04-11 Nps Pharma Inc Compuestos calciliticos, una composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de un medicamento

Also Published As

Publication number Publication date
EP1200076A1 (en) 2002-05-02
BR0012921A (pt) 2002-06-18
NO20020466L (no) 2002-03-20
WO2001008673A1 (en) 2001-02-08
KR20020016928A (ko) 2002-03-06
ZA200200784B (en) 2003-01-29
CO5180628A1 (es) 2002-07-30
AU764716B2 (en) 2003-08-28
MXPA02001204A (es) 2004-05-21
PL353318A1 (en) 2003-11-17
AU6504100A (en) 2001-02-19
PE20010459A1 (es) 2001-06-11
HK1046238A1 (zh) 2003-01-03
ECSP003590A (es) 2002-02-25
EP1200076A4 (en) 2005-02-09
CA2380081A1 (en) 2001-02-08
TR200200278T2 (tr) 2002-06-21
NO20020466D0 (no) 2002-01-29
CN1367687A (zh) 2002-09-04
UY26265A1 (es) 2001-03-16
HUP0202167A3 (en) 2006-07-28
JP2003505502A (ja) 2003-02-12
HUP0202167A2 (en) 2002-10-28
CZ2002360A3 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
PL352911A1 (en) New compounds
GB2357761B (en) Compounds
HK1042303A1 (zh) 新的化合物
EG24178A (en) Calcilytic compounds
EP1104411A4 (en) CALCILYTIC COMPOUNDS
IL144470A0 (en) Calcilytic compounds
IL147875A0 (en) Calcilytic compounds
PL356140A1 (en) New compounds
IL154058A0 (en) Calcilytic compounds
IL150398A0 (en) Calcilytic compounds
IL155522A0 (en) Calcilytic compounds
EP1112073A4 (en) CALCILYTIC COMPOUNDS
GB9902399D0 (en) Compounds
HUP9904624D0 (en) New compounds
SI1202994T1 (en) New compounds
GB9901423D0 (en) Compounds
GB9903239D0 (en) Compounds
GB9901425D0 (en) Compounds
GB9903280D0 (en) Compounds
GB9901429D0 (en) Compounds
GB9901929D0 (en) Compounds
GB9903273D0 (en) Compounds
GB9903243D0 (en) Compounds
GB9903241D0 (en) Compounds
GB9903272D0 (en) Compounds